Cyteir Therapeutics Prices IPO Of 7.40 Mln Shares At $18.00/shr

Cyteir Therapeutics Inc. (CYT) said that it has priced its initial public offering of 7.40 million shares of its common stock at price of $18.00 per share.

In addition, Cyteir has granted the underwriters a 30-day option to purchase up to an additional 1.11 million shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

The shares are scheduled to begin trading on The Nasdaq Global Select Market on June 18, 2021 under the ticker symbol "CYT."

The company expects gross proceeds of the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cyteir, to be about $133 million excluding any exercise of the underwriters' option to purchase additional shares.

The offering is expected to close on June 22, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Delta Air Lines said it sees weather-related flight cancelations as AT&T and Verizon readies for 5G roll out in and around the vicinity of major U.S. airports. Most of the other airlines also confirmed the same as the implementation of the new C-Band 5G service is expected to interfere with the working of onboard aircraft instruments. Financial services firm Morgan Stanley (MS) reported Wednesday a profit for the fourth quarter that increased 10 percent from last year, reflecting 7 percent revenue growth amidst strength in Wealth Management and Investment Management business segments. Bank of America Corp. (BAC) reported Thursday that net income applicable to common shareholders for the fourth quarter grew 30 percent to $6.77 billion from last year's $5.21 billion, with earnings per share increasing to $0.82 from $0.59 in the prior year, reflecting strong operating leverage as revenues...
Follow RTT